Published in Gene Therapy Weekly, September 13th, 1999
The researchers, in identifying a chemical beacon - a protein marker - on the cell, believe the new work will lead to laboratory production of all types of blood cells for transfusions and innovative approaches for bone marrow transplants and gene therapy.
"The hematopoietic stem cell has been considered the elusive Holy Grail of hematology and immunology," said Cesare Peschle, MD, Thomas Jefferson University, who led the work. "Now it has been found and captured by identifying the first specific and functional stem...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.